Jennifer Mannheim

In patients who have type 2 diabetes and low cardiovascular risk, receiving metformin as first-line therapy appears justified.

Researchers found that lower levels of estrogen during menstruation cause women to be more vulnerable to migraines than men.

A pharmacist-led, postdischarge structured telephone follow-up intervention can reduce 30-day and 90-day readmission rates for polypharmacy patients.